Relation of coronary calcium scoring with cardiovascular events in patients with diabetes: The CLARIFY Registry

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever, Björn Dahlöf, Neil R Poulter et al. · The Lancet · 2003 · 3.8K citations

Medicine, Cardiology, Pharmacotherapy +14

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Helen M. Colhoun, D. J. Betteridge, Paul N. Durrington et al. · The Lancet · 2004 · 3.8K citations

Medicine, Pharmacotherapy, Preventive Medicine +9

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

Rory Collins, Jane Armitage, Sarah Parish et al. · The Lancet · 2003 · 2.9K citations

Medicine, Cardiology, Pharmacotherapy +13

10. Cardiovascular Disease and Risk Management: <i>Standards of Medical Care in Diabetes—2022</i>

Diabetes Care · 2021 · 884 citations · Full text

Medicine, Internal Medicine, Diabetology +13

2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2014 · 842 citations · Full text

Medicine, Cardiology, Internal Medicine +14